| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/30/2003 | EP1330258A2 Kahalalide f formulation |
| 07/30/2003 | EP1330253A1 Use of bioactive fraction from cow urine distillate ('go mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients |
| 07/30/2003 | EP1330244A1 Compositions comprising modafinil compounds |
| 07/30/2003 | EP1330239A2 Delayed and sustained release formulations and method of use thereof |
| 07/30/2003 | EP1330238A1 Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
| 07/30/2003 | EP1330237A2 Delivery system for entrapping charged macromolecules and a method for preparing same |
| 07/30/2003 | EP1330221A2 Medical compositions, dressings and methods for treating microbial infections of skin lesions |
| 07/30/2003 | EP1255534B1 Method for the preparation of microspheres which contain colloidal systems |
| 07/30/2003 | EP1233763B1 Transdermal therapeutic systems with improved stability and a method for the production thereof |
| 07/30/2003 | EP1171100B1 Solubilized pharmaceutical composition for parenteral administration |
| 07/30/2003 | EP1157037B1 Gcsf conjugates |
| 07/30/2003 | EP0983058B1 Medicinal aerosol products |
| 07/30/2003 | EP0942780B1 Coated particles, methods of making and using |
| 07/30/2003 | EP0904111B1 Cosmetic and/or pharmaceutical emulsions containing behenyl derivatives |
| 07/30/2003 | EP0904062B1 Sustained release ionic conjugate |
| 07/30/2003 | EP0859628B1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 07/30/2003 | EP0835252B1 Triazole antifungal agents |
| 07/30/2003 | EP0831884B1 Use of bone morphogenic proteins for healing and repair of connective tissue attachment |
| 07/30/2003 | EP0783482B1 Cationic transport reagents |
| 07/30/2003 | EP0779818B1 Liquid immunoglobulin formulations |
| 07/30/2003 | CN1433478A Novel colloid synthetic vectors for gene therapy |
| 07/30/2003 | CN1433477A Method of achieving persistent transgene expression |
| 07/30/2003 | CN1433423A Mono and disaccharide derivatives |
| 07/30/2003 | CN1433324A Interferon gamma conjugates |
| 07/30/2003 | CN1433319A Enzyme treatment for infection |
| 07/30/2003 | CN1433318A Vascular endothelial growth factor-2 |
| 07/30/2003 | CN1433316A Biologically active agents and drugs |
| 07/30/2003 | CN1433314A Antimicrobial compositions and methods of use |
| 07/30/2003 | CN1433311A Methods for making sustained release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 07/30/2003 | CN1433310A Medicinal compositions containing camptothecin derivative and regulating agent |
| 07/30/2003 | CN1433309A Dual-release compositions of cyclooxygenase-2-inhibitor |
| 07/30/2003 | CN1433307A Prostaglandin compounds for treating congestive heart failure |
| 07/30/2003 | CN1433300A Treatment agent |
| 07/30/2003 | CN1432592A Dissolving and filming method of egg shell membrane |
| 07/30/2003 | CN1432410A External prepn for stopping skin pain quickly |
| 07/30/2003 | CN1432409A Method of covering bitter of Chinese medicine with starch paste |
| 07/30/2003 | CN1116104C Method capable of scale preserving bioactivity matter by drying |
| 07/30/2003 | CN1116076C Compisition for prevention and treatment of helminth infections |
| 07/30/2003 | CN1116061C Traditional Chinese medicine fused magnetized xenogenous protein for treating prolapse of lumbar intervertebrai disc and cervical spondylopathy and preparation process thereof |
| 07/30/2003 | CN1116039C Molecular dispersion composition with enhanced bioavailability |
| 07/30/2003 | CN1116030C Compositions for inhalation |
| 07/30/2003 | CN1116029C Tablet allowing prolonged release of sodium salt of tianeptine after administration by oral |
| 07/29/2003 | US6600010 Biodegradable terephthalate polyester-poly (phosphate) polymers, compositions, articles, and methods for making and using the same |
| 07/29/2003 | US6599944 Ophtalmic compound with extended dwell time on the eye |
| 07/29/2003 | US6599931 Test system for characterizing the compatibility of bioactive substances and polyvinylpyrrolidone |
| 07/29/2003 | US6599928 Administering agent that inhibits the contraction or migration of smooth muscle cells; sustained dosage; biological stents |
| 07/29/2003 | US6599897 Quetiapine granules |
| 07/29/2003 | US6599724 Pharmaceutical composition for use in the treatment of blood disorders |
| 07/29/2003 | US6599720 Methods for making poly-β-1→4-N-acetylglucosamine |
| 07/29/2003 | US6599627 Microencapsulation of drugs by solvent exchange |
| 07/29/2003 | US6599535 Bioavailability of drug substance, are convenient to administer, and are stable |
| 07/29/2003 | US6599533 Homogenous water-free formulations containing glycerophospholipids and polar or lipophilic substances, method for the production thereof |
| 07/29/2003 | US6599530 Oral compacted composition comprising catechol derivatives |
| 07/29/2003 | US6599528 Mechanically stable pharmaceutical presentations form containing liquid or semisolid surface-active substances |
| 07/29/2003 | US6599527 Preparation of pharmaceutical compositions |
| 07/29/2003 | US6599519 Biodegradable poly(alkylene oxide)-poly(p-dioxanone) block copolymer soluble in organic solvents, and drug delivery composition comprising same |
| 07/29/2003 | US6599513 For use in personal care and dermatological products |
| 07/29/2003 | US6599507 Composition for the treatment of immune deficiencies and methods for its preparation and use |
| 07/29/2003 | US6599505 Leukemias, both acute and chronic; conjugate of a protein exhibiting binding specificity for an antigen domain of CD33 protein and a gelonin toxin selected from the group consisting of recombinant gelonin and fragments |
| 07/29/2003 | US6599498 Enhanced magnetic resonance imaging agent and a hematinic agent; carboxyalkylated reduced polysaccharides coated ultrasmall superparamagnetic iron oxides; carboxymethyl reduced dextran as a plasma extender |
| 07/29/2003 | US6598371 Capsules |
| 07/29/2003 | CA2288038C Polyethylene glycol-interferon alpha conjugates for therapy of infection |
| 07/29/2003 | CA2269745C Improved treatment of migraine headache |
| 07/29/2003 | CA2172159C Improved pharmaceutical formulation |
| 07/29/2003 | CA2133838C Immunotoxins directed against cd33 related surface antigens |
| 07/29/2003 | CA2132982C Catalytic antibodies against cocaine and methods of using and producing same |
| 07/29/2003 | CA2113914C Phospholipid derivative and liposome containing it |
| 07/29/2003 | CA2109502C Water insoluble derivatives of polyanionic polysaccharides |
| 07/29/2003 | CA2094280C A method for transplanting cells into the brain and therapeutic uses therefor |
| 07/29/2003 | CA2082777C (quinolin-2-ylmethoxy) indole/cyclodextrin complex |
| 07/29/2003 | CA2012125C Use of functional derivatives of the intercellular adhesion molecule icam-1 in anti-viral therapy |
| 07/28/2003 | CA2398226A1 Increased-dosage nelfinavir tablet and method of making same |
| 07/24/2003 | WO2003060142A2 Compositions and methods for controlled release |
| 07/24/2003 | WO2003060076A2 Povidone-containing carriers for polypeptide growth factors |
| 07/24/2003 | WO2003060074A2 Novel metastasis suppressor gene on human chromosome 8 |
| 07/24/2003 | WO2003059988A2 Biodegradable polyketal polymers and methods for their formation and use |
| 07/24/2003 | WO2003059987A1 Multidrop tree branching functional polyethylene glycol, the preparation method and the use of it |
| 07/24/2003 | WO2003059973A2 Block copolymers |
| 07/24/2003 | WO2003059942A2 Peptides and peptidomimetics having anti-proliferative activity and their use |
| 07/24/2003 | WO2003059924A1 Novel binding epitopes for helicobacter pylori and use thereof |
| 07/24/2003 | WO2003059848A2 Hybrid immobilized catalytic system with controlled permeability |
| 07/24/2003 | WO2003059436A2 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 07/24/2003 | WO2003059424A1 Methods and systems for operating an aerosol generator |
| 07/24/2003 | WO2003059394A1 Composition for transporting oligonucleotides through the blood brain barrier and their use for treating central nervous system diseases |
| 07/24/2003 | WO2003059393A1 Pantoprazole cyclodextrin inclusion complexes |
| 07/24/2003 | WO2003059392A2 Conjugate for treating prokaryotic infections |
| 07/24/2003 | WO2003059391A2 Viscoelastics for ocular surgery |
| 07/24/2003 | WO2003059389A1 Medicinal compositions for improving oral absorption |
| 07/24/2003 | WO2003059382A2 Pharmaceutical compositions comprising polyanionic polymers and amphiphilic block copolymers and methods of use thereof to improve gene expression |
| 07/24/2003 | WO2003059363A1 Methods and compositions for oxygen transport comprising a high oyzgen affinity |
| 07/24/2003 | WO2003059358A1 25-hydroxy vitamin d3 compositions |
| 07/24/2003 | WO2003059349A1 Sedative non-benzodiazepine formulations |
| 07/24/2003 | WO2003059344A1 Suppositories containing indole derivative |
| 07/24/2003 | WO2003059338A1 Process for producing liquid preparation containing branched amino acids |
| 07/24/2003 | WO2003059333A2 Stimulation of the immune system with polydextrose |
| 07/24/2003 | WO2003059331A2 Medicinal aerosol compositions with an amide and/or ester containing excipient compound |
| 07/24/2003 | WO2003059329A2 Polytartrate composition |
| 07/24/2003 | WO2003059328A1 Formulations |
| 07/24/2003 | WO2003059327A1 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof |
| 07/24/2003 | WO2003059326A1 Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties |